Your browser doesn't support javascript.
loading
Botulinum Toxin: An Effective Treatment for Flushing and Persistent Erythema in Rosacea.
Luque, Andres; Rojas, Aida Paola; Ortiz-Florez, Andrea; Perez-Bernal, Juliana.
Afiliação
  • Luque A; All authors are with Hospital Universitario Centro Dermatológico Federico Lleras in Bogotá, Colombia.
  • Rojas AP; All authors are with Hospital Universitario Centro Dermatológico Federico Lleras in Bogotá, Colombia.
  • Ortiz-Florez A; All authors are with Hospital Universitario Centro Dermatológico Federico Lleras in Bogotá, Colombia.
  • Perez-Bernal J; All authors are with Hospital Universitario Centro Dermatológico Federico Lleras in Bogotá, Colombia.
J Clin Aesthet Dermatol ; 14(3): 42-45, 2021 Mar.
Article em En | MEDLINE | ID: mdl-33841616
Botulinum toxin has been used to treat persistent erythema and flushing in rosacea for several years. Here, we describe two women and one man, each with rosacea with flushing and permanent erythema refractory to conventional treatment, who achieved satisfactory and lasting results following intradermal application of botulinum toxin. Two different botulinum toxin types were used. Toxin concentrations of 3.75U per 0.1 mL (abobotulinum) and 1.25U per 0.1 mL (incobotulinum) were used for each patient were used for each patient. The outcomes were measured using polarized photography to evaluate the decrease in vascular involvement. In the three cases presented here, botulinum toxin was effective for controlling erythema and flushing associated with rosacea; we also observed a prolonged duration of these improvements without the rebound effect of topical therapies.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Aesthet Dermatol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Aesthet Dermatol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Estados Unidos